| 000 | 01867 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250513230828.0 | ||
| 264 | 0 | _c20010322 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1086/318538 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPerez, E E | |
| 245 | 0 | 0 |
_aHuman immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cFeb 2001 |
||
| 300 |
_a579-88 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease _xgenetics |
| 650 | 0 | 4 |
_aHIV Reverse Transcriptase _xgenetics |
| 650 | 0 | 4 |
_aHIV-1 _xenzymology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPhylogeny |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRose, S L | |
| 700 | 1 | _aPeyser, B | |
| 700 | 1 | _aLamers, S L | |
| 700 | 1 | _aBurkhardt, B | |
| 700 | 1 | _aDunn, B M | |
| 700 | 1 | _aHutson, A D | |
| 700 | 1 | _aSleasman, J W | |
| 700 | 1 | _aGoodenow, M M | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 183 _gno. 4 _gp. 579-88 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1086/318538 _zAvailable from publisher's website |
| 999 |
_c11109904 _d11109904 |
||